In addition, we were able to conduct a meta-analysis to quantify the contribution of genetic polymorphisms of IGF1 (rs6214C>T), IRS1 (rs1801278G>A), and IRS2 (rs1805097G>A) to CRC risk. This evidence concerns the gene IGF1 and colorectal carcinoma.